Diabetes Metab J.  2015 Apr;39(2):114-116. 10.4093/dmj.2015.39.2.114.

How Can We Easily Measure Glycemic Variability in Diabetes Mellitus?

• Chon S

• KMID: 1805893
• DOI: http://doi.org/10.4093/dmj.2015.39.2.114

Abstract

No abstract available.

MeSH Terms

Diabetes Mellitus*

Reference

1. Candido R. Which patients should be evaluated for blood glucose variability? Diabetes Obes Metab. 2013; 15:Suppl 2. 9–12.

2. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997; 46:271–286.

3. Saisho Y. Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? Int J Mol Sci. 2014; 15:18381–18406.

4. Aryangat AV, Gerich JE. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk. Vasc Health Risk Manag. 2010; 6:145–155.

5. Murata GH, Hoffman RM, Shah JH, Wendel CS, Duckworth WC. A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: the Diabetes Outcomes in Veterans Study (DOVES). Arch Intern Med. 2004; 164:1445–1450.

6. Kilpatrick ES, Rigby AS, Goode K, Atkin SL. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia. 2007; 50:2553–2561.

7. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care. 2010; 33:17–22.

8. Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009; 11:Suppl 1. S55–S67.

9. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970; 19:644–655.

10. Rodbard D. The challenges of measuring glycemic variability. J Diabetes Sci Technol. 2012; 6:712–715.

11. Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006; 29:1214–1219.

12. Kim MJ, Jung HS, Hwang-Bo Y, Cho SW, Jang HC, Kim SY, Park KS. Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta Diabetol. 2013; 50:505–510.

13. Chon S, Lee YJ, Fraterrigo G, Pozzilli P, Choi MC, Kwon MK, Chin SO, Rhee SY, Oh S, Kim YS, Woo JT. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus. Diabetes Technol Ther. 2013; 15:455–460.

14. Seok H, Huh JH, Kim HM, Lee BW, Kang ES, Lee HC, Cha BS. 1,5-Anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes. Diabetes Metab J. 2015; 39:164–170.

15. Dungan KM. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn. 2008; 8:9–19.

16. Dworacka M, Winiarska H. The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients. Dis Markers. 2005; 21:127–132.

17. Beck R, Steffes M, Xing D, Ruedy K, Mauras N, Wilson DM, Kollman C. Diabetes Research in Children Network (DirecNet) Study Group. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. Pediatr Diabetes. 2011; 12:690–695.

18. Matsumoto H, Murase-Mishiba Y, Yamamoto N, Sugitatsu-Nakatsukasa S, Shibasaki S, Sano H, Terasaki J, Imagawa A, Hanafusa T. Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes. Intern Med. 2012; 51:1315–1321.